Replies to post #192679 on Biotech Values

[north40000]

Did you notice any mentions of ATOH-1 gene therapy[GNVC] for hearing loss on that large slide set?

[JohnWayne]

NVS Investor Presentation -- Do you know if a webcast/replay will be available?

[masterlongevity]

$NVS WHat program are they planning to take into Phase 3 for AD.? The CAD-106 vaccine program did not look good as they didnt produce good titres in a large % of pts. If thats going forward, then JnJ/Pfe should definitely push ACC-001 forward. It actually looked quite good, but JnJ/PFE seem to be in a complete holding pattern on AD, despite equal or lesser drugs moving forward